Type-2-diabetes Mellitus Trials in muscle shoals, united states
Conditions / Type-2-diabetes Mellitus / muscle shoals, united states
Type-2-diabetes Mellitus is a medical condition with active clinical research programs worldwide.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02294474 | Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine | COMPLETED | PHASE3 |
| NCT00856284 | Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT01699737 | Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE2 |
| NCT01864174 | Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes | COMPLETED | PHASE4 |
| NCT00484198 | Study of Rivoglitazone in Type 2 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT00976937 | 24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years | COMPLETED | PHASE3 |
| NCT00789737 | Welchol as Monotherapy for Type 2 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT01885260 | Safety, Tolerability and Efficacy of ISIS-GCGRRx in Type 2 Diabetes | COMPLETED | PHASE2 |
| NCT00549757 | Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) | TERMINATED | PHASE3 |
| NCT01658501 | Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM | COMPLETED | PHASE2 |